US Stock MarketDetailed Quotes

RDHL Redhill Biopharma

Watchlist
  • 0.420
  • -0.008-1.84%
Close Apr 24 16:00 ET
13.38MMarket Cap0.10P/E (TTM)

About Redhill Biopharma Company

RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolRDHL
Company NameRedhill Biopharma
Listing DateDec 27, 2012
Founded2009
CEOMr. Dror Ben-Asher
MarketNASDAQ
Employees113
Securities TypeDR
ADS Ratio1.0 : 400.0
Fiscal Year Ends12-31
Address21 Ha'arba'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6473921
Phone972-3-541-3131
Websitehttp://www.redhillbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dror Ben-Asher
  • Chairman of the Board and Chief Executive Officer
  • 594.61K
  • Razi Ingber
  • Chief Financial Officer
  • 354.22K
  • Adi Frish
  • Chief Corporate and Business Development Officer
  • 353.70K
  • Rick D. Scruggs
  • Director and Chief Commercial Officer
  • 469.80K
  • Guy Goldberg
  • Chief Business Officer
  • 406.54K
  • Gilead Raday
  • Chief Operating Officer
  • 379.96K
  • Dr. Reza Fathi
  • Senior Vice President, Research and Development
  • --
  • Ofer Tsimchi
  • Independent Director
  • --
  • Dr. Shmuel Cabilly
  • Independent Director
  • --
  • Dr. Kenneth Reed
  • Independent Director
  • --
  • Eric Swenden
  • Independent Director
  • --
  • Alla Felder
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg